| 000 | 01079 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514004126.0 | ||
| 264 | 0 | _c20010816 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a1389-2010 | ||
| 024 | 7 |
_a10.2174/1389201003378870 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeissig, V | |
| 245 | 0 | 0 |
_aMitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical biotechnology _cDec 2000 |
||
| 300 |
_a325-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCations _xadministration & dosage |
| 650 | 0 | 4 |
_aDNA, Mitochondrial _xgenetics |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aProteins _xchemistry |
| 700 | 1 | _aTorchilin, V P | |
| 773 | 0 |
_tCurrent pharmaceutical biotechnology _gvol. 1 _gno. 4 _gp. 325-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1389201003378870 _zAvailable from publisher's website |
| 999 |
_c11395052 _d11395052 |
||